This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2004 Remove Patients Remove Pharmaceutical products Related Topics
Ethics Competition Healthcare Provider Prescription Specialization Food and Drug Administration Leads Doctors Prospecting Physicians More Related Topics >
article thumbnail

2022 spells change for EU pharmaceutical legislation

European Pharmaceutical Review

JUNE 24, 2022

This means numerous key aspects of how pharmaceuticals are regulated in the EU could be affected, from costing and reimbursement to intellectual property rights, incentives and more. Stakeholders in the EU often use the risk-adjusted Net Present Value (rNPV) investment model to determine whether to invest in a pharmaceutical product.

Pharmaceutical 96
Pharmaceutical Medicine Marketing Competition 96
article thumbnail

Uri Goren

Cadensee

JULY 20, 2021

Uri Goren is the head of digital engagement and capabilities at Teva Pharmaceuticals, and just recently became a member of the National Advisory Board for digital health for the Israel Ministry of Health. 02:25 Uri Goren talks about his road to become a trailblazer and advocate for patient-centric healthcare. Show Notes.

Food and Drug Administration 52
Food and Drug Administration Doctors Healthcare Healthcare 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 8,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024